Mark Childs

Title: Mark Childs: Innovator in Microfluidic Technology

Introduction

Mark Childs is a notable inventor based in Formby, GB. He has made significant contributions to the field of microfluidics, particularly through his innovative patents. With a total of 2 patents, Childs has demonstrated his expertise and commitment to advancing technology in this area.

Latest Patents

Childs' latest patents include a droplet microfluidic device and methods of sensing the result of an assay therein. This method involves several steps, including dispensing a sample droplet onto a first portion of an electrode array and a reagent droplet onto a second portion. The process controls actuation voltages to mix these droplets into a product droplet. By sensing a dynamic property of the product droplet, the assay result can be determined. The dynamic properties include the moveable state, split-able state, and viscosity, which influence the transport properties of the droplet on the electrode array. This method is particularly useful for performing an amoebocyte lysate (LAL) assay.

Career Highlights

Mark Childs is currently associated with Sharp Life Science (EU) Limited, where he continues to innovate in the field of microfluidics. His work has positioned him as a key player in the development of advanced technologies that enhance assay performance and efficiency.

Collaborations

Childs collaborates with talented individuals such as Benjamin James Hadwen and Adrian Marc Simon Jacobs. These partnerships contribute to the innovative environment in which he works, fostering creativity and technological advancement.

Conclusion

Mark Childs is a prominent inventor whose work in microfluidic technology has led to significant advancements in assay methods. His contributions are paving the way for future innovations in this critical field.